LAVA Therapeutics
LVTX
LVTX
14 hedge funds and large institutions have $9.26M invested in LAVA Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
2
Calls
$34K
Puts
–
Net Calls
+$34K
Net Calls Change
+$9K
Top Buyers
1 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.33M |
2 |
Morgan Stanley
New York
|
+$62.1K |
3 |
Citadel Advisors
Miami,
Florida
|
+$34.1K |
Top Sellers
1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$824K |
2 |
AG
Artal Group
Luxembourg
|
-$294K |
3 |
Millennium Management
New York
|
-$56.8K |
4 |
AWG
Alpha Wave Global
New York
|
-$1.88K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$790 |